Abstract:Abstract Immunotherapy is effective in the treatment of melanoma due to its immunogenicity. In recent years, researchers have identified LTP is rich in active substances that can induce apoptosis in tumor cells and trigger an immune response. However, it is unclear how LTP works to antitumor by enhancing immune cell function. Therefore, the purpose of this study is to investigate the effects of direct and indirect LTP treatments on the quantity and function of Treg cells and CD8+ T cells in B16-F10 melanoma-bearing mice and their associated mechanisms. The results revealed that both direct and indirect LTP treatments were effective at inhibiting tumor growth and extending the survival of B16-F10 melanoma-bearing mice. In addition, both direct and indirect LTP treatments reduced the number of Treg cells and improved the immune function of CD8+ T cells in the spleen and tumor. Nevertheless, the indirect LTP treatment proved to be more effective than the LTP direct treatment. Mechanistic studies demonstrated that direct LTP treatment might affect the quantity and function of Treg cells and CD8+ T cells by modulating cytokine level changes. However, indirect LTP treatment might have a greater tumor immunotherapeutic potential by inhibiting the activation of key protein molecules in the IL-6/STAT3 signaling pathway and regulating cytokine level changes. In conclusion, this study reveals that LTP exerts an anti-melanoma effect by regulating the level and function of Treg cells and CD8+ T cells. This study is expected to provide new ideas for LTP anti-tumor immunotherapy.

Research Advances and Application Prospect of Low-Temperature Plasma in Tumor Immunotherapy

Research progress and key problems in low temperature plasmatreating mammalian cells and living tissues

Immunogenic Cell death Induced by Low Temperature Plasma to Activate Antitumor Immunity and Enhance Therapeutic Efficiency

Applications and challenges of low temperature plasma in pharmaceutical field

Research Advances of Anti-Tumor Immune Response Induced by Pulse Electric Field Ablation

Low Temperature Plasma Suppresses Proliferation, Invasion, Migration and Survival of SK-BR-3 Breast Cancer Cells

Research Progress on the Mechanism of Anti-Tumor Immune Response Induced by TTFields

Preparation of a Plasma‐Induced Dendritic Cell Vaccine and Its Anti‐Tumor Immunity in a Murine Model of Melanoma

Effect of low temperature plasma on the transcriptome of breast cancer cells

Plasma Medicine and The Application in Tumor Therapy

Effect and mechanism of low-temperature plasma on the quantity and function of Treg and CD8+ T cells in B16-F10 melanoma-bearing mice

Comparison of direct and indirect low-temperature plasma triggering immunogenic cell death in B16F10 melanoma

Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy

Research progress on anti-tumor immune effect of cryoablation

Antitumor effects of plasma‐activated solution on a murine melanoma model in vivo and in vitro

[Current Status and Progress of Thermal Ablation Combined with Immunotherapy for Lung Tumors]

Non‑thermal Plasma Inhibits Tumor Growth and Proliferation and Enhances the Sensitivity to Radiation in Vitro and in Vivo.

Progresses and Perspectives of Tumor Treating Fields

Recent Advances in Thermal Treatment Techniques and Thermally Induced Immune Responses Against Cancer.

Low-Temperature Plasma Suppresses Proliferation and Induces Apoptosis in Lung Cancer Cells by Regulating the miR-203a/BIRC5 Axis

Low-Temperature Plasma Suppresses Proliferation and Induces Apoptosis in Lung Cancer Cells by Regulating the miR-203a/BIRC5 Axis.